Genex Pharmaceutical, Inc.
GENX · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $2 | $2 |
| % Growth | 32.8% | -2.1% | 6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $3 | $2 | $2 | $2 |
| % Margin | 88.8% | 91.1% | 87.9% | 88% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $0 | $0 |
| SG&A Expenses | $2 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $1 | $1 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $1 | $1 | $1 |
| Operating Income | $0 | $1 | $1 | $1 |
| % Margin | 14.4% | 34.7% | 37% | 42.2% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $1 | $1 | $1 |
| % Margin | 10.6% | 25.4% | 25.1% | 43.1% |
| EPS | 0.019 | 0.03 | 0.04 | 0.06 |
| % Growth | -36% | -25% | -33.3% | – |
| EPS Diluted | 0.019 | 0.03 | 0.04 | 0.06 |
| Weighted Avg Shares Out | 18 | 18 | 18 | 18 |
| Weighted Avg Shares Out Dil | 18 | 18 | 18 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 24.4% | 37% | 39.4% | 44.7% |